Understanding HPV and Cervical Cancer: A Call for Awareness

Cervical cancer is a significant health issue affecting women worldwide. Fortunately enough, it's one of the most preventable types of cancer. The key to prevention lies in understanding the role of ...

The perfect match for your IFA testing

Due to the high specificity of the results, indirect immunofluorescence assays (IFA) are still one of the most widely used diagnostic tools in autoimmunity. However, the challenges of processing these ...

Well prepared for the cold season: A new RSV assay supplementing the EURORealTime product family

he cold season 2022 has left marks: Nearly two years ago, an extraordinarily severe RSV wave brought children’s hospitals and paediatric practices, as well as the parents of affected children to their ...

Covering all bases – our portfolio for rheumatology

Diagnostics of the different autoimmune-related rheumatic diseases pose a particular challenge to rheumatologists: They are confronted with at least 400 inflammatory joint, connective tissue or ...

Abstracts of the 16th Dresden Symposium on Autoantibodies

Achievements and Challenges in Research, Diagnostics and Therapy of Autoimmune Diseases
Abstract collection 2023

Microscopy with LED technology: The EUROStar series

Do you remember 2005?
It was the year of USB flash drives, Bluetooth headsets, digital cameras – and the EUROStar. The first EUROIMMUN microscope was designed to simplify microscopy and eliminate the ...

Let’s change the perspective together! — ChLIA for allergy diagnostics

In allergy diagnostics, chemiluminescence immunoassays (ChLIA) contribute to quick and precise identification of sensitisations to allergens. They allow specific determination of IgE antibodies in the ...

Novel cell-based assay for autoantibody detection in demyelination

A novel cell-based immunofluorescence assay (CBA) provides sensitive and specific detection of IgM antibodies against myelin-associated glycoprotein (MAG), as demonstrated in a study published in ...

Neurological symptoms: a diagnostic challenge

There is a huge variety of neurological diseases and it often takes specialists a long time to figure out the cause of a patient’s symptoms. Doctors regularly encounter patients with unspecific ...

Novel autoantibody against DAGLA discovered in cerebellitis

Diacylglycerol lipase alpha (DAGLA) has been identified as a novel autoantibody target in patients with rapid progressive cerebellar ataxia. The autoantibodies were characterised as part of a ...

Back to top